会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明公开
    • 카테콜 N-메틸히드라자이드 카바믹에스테르 유도체 및 그제조방법
    • CATECHOL N-甲基乙酰胺碳水化合物衍生物及其制备方法
    • KR1020020094791A
    • 2002-12-18
    • KR1020010033237
    • 2001-06-13
    • 씨제이 주식회사
    • 이건호장명식송석범김종훈이정근이재목서병철류춘선전형옥신재규
    • C07C251/28
    • PURPOSE: A novel catechol N-methylhydrazide carbamic ester derivative, its preparation method and a pharmaceutical composition containing the derivative are provided, which derivative has the inhibition effect on phosphodiesterase (PDE) IV or a tumor necrosis factor (TNF). CONSTITUTION: The catechol N-methylhydrazide carbamic ester derivative is represented by the formula 1, wherein R1 is a cycloalkyl group of C3-C7, an indanyl group or a benzyl group; R2 is a methyl group; Y is -C(=O)O-; R3 is an alkyl group of C1-C6 substituted or unsubstituted with one or two halogen atom or compound of C1-C3 selectively; an cycloalkyl group of C1-C6 substituted or unsubstituted with one or two compound of C1-C3 selectively; a phenyl group substituted or unsubstituted with one or two nitro group, nitryl group, halogen atom, alkyl group of C1-C3 or alkoxy group of C1-C3 selectively; or a benzyl group substituted or unsubstituted with one or two nitro group, nitryl group, halogen atom selectively, and the halogen atom is Cl, F or Br.
    • 目的:提供新型儿茶酚N-甲基酰肼氨基甲酸酯衍生物及其制备方法和含有该衍生物的药物组合物,该衍生物对磷酸二酯酶(PDE)IV或肿瘤坏死因子(TNF)具有抑制作用。 构成:儿茶酚N-甲基酰肼氨基甲酸酯衍生物由式1表示,其中R1是C3-C7,茚满基或苄基的环烷基; R2是甲基; Y是-C(= O)O-; R3是被一个或两个卤素原子取代或未取代的C1-C6烷基或C1-C3化合物选择性的; 被一个或两个C1-C3化合物选择性取代或未取代的C1-C6的环烷基; 被一个或两个硝基取代或未取代的苯基,硝基,卤素原子,C1-C3的烷基或C1-C3的烷氧基选择性地; 或被一个或两个硝基取代或未取代的苄基,硝基,选择性地卤素原子,卤素原子是Cl,F或Br。